Article History
First Online: 3 March 2023
Competing interests
: J.C.M is the chief executive officer of Mycardium AI and has served on advisory boards for Genzyme and Sanofi. L.R.L. has received consulting/speaker fees from Bristol Myers Squibb, NovoNordisk and Sanofi, and is funded by a project grant from Bristol Myers Squibb. G.J. declares no competing interests.